Inventiva (IVA) to Release Quarterly Earnings on Wednesday

Inventiva (NASDAQ:IVA) is set to release its earnings data before the market opens on Wednesday, September 25th. Analysts expect Inventiva to post earnings of ($0.50) per share for the quarter. Persons that wish to listen to the company’s earnings conference call can do so using this link.

Inventiva Stock Up 6.8 %

IVA opened at $2.19 on Tuesday. Inventiva has a one year low of $2.05 and a one year high of $4.75. The business has a 50 day simple moving average of $2.29 and a two-hundred day simple moving average of $3.01.

About Inventiva

Inventiva SA, a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH) and other diseases. Its lead product candidate is Lanifibranor, which is in Phase III clinical trial to treat NASH. The company also develops Odiparcil for the treatment of patients with mucopolysaccharidoses type VI.